27 May, 2017
Yet another important factor while evaluating a good buy/sell decision for CEL-SCI Corporation (CVM) is its Earnings per Share or EPS. The average volume of a stock suggests the liquidity of a particular company. One obvious way to identify high earnings per share growth companies is to find companies that have demonstrated such growth over the past 5 to 10 years. The Market Capitalization of the company stands at 19.01 Million.
Zacks offers analysts with an Average Broker Rating (or ABR), basing it on sell-side recommendations.
Bristow Group Inc (NYSE:BRS) have shown a low EPS growth of -20.70% in the last 5 years and has earnings growth of -788.90% yoy.
CEL-SCI Corporation (:CVM) shares are gapping higher 2.35% pre-market with a price of $0.09 on the stock.
CEL-SCI Corporation (CVM) belongs to the "Healthcare" sector with an industry focus on "Biotechnology", with Mr. Geert R. Kersten Esq.as Chief Exec. Officer, Treasurer and Director.
The counter witnessed a trading volume of 0.14 million shares versus an average volume of 0.22 million shares during last trading session. The lowest price the stock reached in the last trading day was $4.03 and compares with the $1.1 52-week low.
CEL-SCI Corporation's 20-Day Simple Moving Average is -20.34%. Breaking that down further, it has performed 5.83% for the week, 11.51% for the month, 31.29% over the last quarter, 67.09% for the past half-year and 65.72% for this previous year. The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00. The target implies a 11.11% spike from where the shares are now trading. Taking a wider view, the current separation from the 52-week high is -91.49%, and the distance from the 52-week low is presently 117.86%. Likewise, the positive performance for the quarter was recorded as 6.57% and for the year was 29.43%, while the YTD performance remained at 8.42%.
